CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn’s disease
References
- 1. FLOYD DN, LANGHAM S, SÉVERAC HC, LEVESQUE BG.
The economic and quality-of-life burden of Crohn’s disease in Europe and the United States, 2000 to 2013: a systematic review . Digestive diseases and sciences. 2015;60 (2):299-312. - 2. EBRAHIMPOUR S, SHAHBAZIM, KHALILI A, TAHOORI MT, ZAVARAN HOSSEINI A, AMARI A,
et al .Elevated levels of IL-2 and IL-21 produced by CD4+ T cells in inflammatory bowel disease . J Biol Regul Homeost Agents. 2017;31 (2):279-87. - 3. HASANJANI RM, BAYANI M, SOLEIMANI AS, MOHAMMADNIA-AFROUZI M, NOURI H, EBRAHIMPOUR S.
Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis . Journal of biological regulators and homeostatic agents. 2016;30 (3):675. - 4. GRANT CR, LIBERAL R, MIELI-VERGANI G, VERGANI D, LONGHI MS.
Regulatory T-cells in autoimmune diseases: challenges, controversies and—yet—unanswered questions . Autoimmunity reviews. 2015;14 (2):105-16. - 5. MOHAMMADNIA-AFROUZI M, ZAVARAN HOSSEINI A, KHALILI A, ABEDIANKENARI S, HOSSEINI V, MALEKI I.
Decrease of CD4+ CD25+ CD127low FoxP3+ regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients . Autoimmunity. 2015;48 (8):556-61. - 6. MOHAMMADNIA-AFROUZI M, SHAHBAZI M, DAMAVANDI SB, GANJI GF, EBRAHIMPOUR S.
Regulatory T-cell: Regulator of Host Defense in Infection . Journal of Molecular Biology Research. 2017;7 (1):9. - 7. BACCHETTA R, BARZAGHI F, RONCAROLO MG.
From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation . Annals of the New York Academy of Sciences. 2016. - 8. CAUDY AA, REDDY ST, CHATILA T, ATKINSON JP, VERBSKY JW.
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked–like syndrome, and defective IL-10 expression from CD4 lymphocytes . Journal of Allergy and Clinical Immunology. 2007;119 (2):482-7. - 9. LI Y, WANG Y, LIU Y, WANG Y, ZUO X, LI Y,
et al .The Possible Role of the Novel Cytokines IL-35 and IL-37 in Inflammatory Bowel Disease . Mediators of Inflammation. 2014;2014 :10. - 10. LIU Z, FENG B-S, YANG S-B, CHEN X, SU J, YANG P-C.
Interleukin (IL)-23 suppresses IL-10 in inflammatory bowel disease . Journal of Biological Chemistry. 2012;287 (5):3591-7. - 11. HARVEY RF, BRADSHAW JM.
A simple index of Crohn’s-disease activity . Lancet. 1980;1 (8167):514. - 12. KONTIAINEN S, SCHEININT, HALME L.
Number of activated T-helper cells and NK cells in peripheral blood is decreased in severe Crohn’s disease . Apmis. 1996;104 (5):355-61. - 13. DI SABATINO A, BIANCHERI P, PICONESE S, ROSADO MM, ARDIZZONE S, ROVEDATTI L,
et al .Peripheral regulatory T cells and serum transforming growth factor-β: Relationship with clinical response to infliximab in Crohn’s disease . Inflammatory bowel diseases. 2010; 16(11):1891-7. - 14. MAUL J, LODDENKEMPER C, MUNDT P, BERG E, GIESE T, STALLMACH A,
et al .Peripheraland intestinal regulatory CD4+ CD25 high T cells in inflammatory bowel disease . Gastroenterology. 2005;128 (7):1868-78. - 15. GUIDI L, FELICE C, PROCOLI A, BONANNO G, MARTINELLI E, MARZO M,
et al .FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents . BioMed Research International. 2013;2013 :286368. - 16. MAKITA S, KANAI T, OSHIMA S, URAUSHIHARA K, TOTSUKA T, SAWADA T,
et al. CD4+ CD25bright T cells in human intestinal lamina propria as regulatory cells . The Journal of Immunology. 2004;173 (5):3119-30. - 17. CUADRADO E, ALONSO M, DE JUAN MD, ECHANIZ P, ARENAS JI.
Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis . World J Gastroenterol. 2008;14 (10):15217. - 18. UENO A, JIJON H, CHAN R, FORD K, HIROTA C, KAPLAN GG,
et al .Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients . Inflamm Bowel Dis. 2013;19 (12):2522-34. - 19. SARUTA M, YU QT, FLESHNER PR, MANTEL PY, SCHMIDT-WEBER CB, BANHAM AH,
et al .Characterization of FOXP3+CD4+ regulatory T cells in Crohn’s disease . Clin Immunol. 2007;125 (3):281-90. - 20. S
un M, He C, Cong Y, Liu Z.Regulatory immune cells in regulation of intestinal inflammatory response to microbiota . Mucosal immunology. 2015;8 (5):969-78. - 21. CHAUDHRY A, SAMSTEIN RM, TREUTING P, LIANG Y, PILSMC, HEINRICH J-M,
et al .Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation . Immunity. 2011;34 (4):566-78. - 22. COLLISON LW, CHATURVEDI V, HENDERSON AL, GIACOMIN PR, GUY C, BANKOTI J,
et al. IL-35-mediated induction of a potent regulatory T cell population . Nature immunology. 2010;11 (12):1093-101. - 23. FRANKE A, BALSCHUN T, KARLSEN TH, SVENTORAITYTE J, NIKOLAUS S, MAYR G,
et al .Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility . Nat Genet. 2008;40 (11):1319-23. - 24. IYER SS, CHENG G.
Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease . Critical reviews in immunology. 2012;32 (1):23-63. - 25. MOHAMMADNIA-AFROUZI M, HOSSEINI AZ, KHALILI A, ABEDIANKENARI S, AMARI A, AGHILI B,
et al. Altered microRNA expression and immunosuppressive cytokine production by regulatory T cells of ulcerative colitis patients . Immunological investigations. 2016;45 (1):63-74.
Language: English
Page range: 158 - 166
Submitted on: Jan 13, 2018
Published on: Aug 29, 2018
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2018 Ali Khalili, Soheil Ebrahimpour, Iradj Maleki, Saeid Abediankenari, Mousa Mohammadnia Afrouzi, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.